[1] |
Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.
Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer
[J]. Journal of International Oncology, 2024, 51(6): 321-325.
|
[2] |
Sa Qiang, Xu Hangcheng, Wang Jiayu.
Advances in immunotherapy for breast cancer
[J]. Journal of International Oncology, 2024, 51(4): 227-234.
|
[3] |
Qian Xiaotao, Shi Ziyi, Hu Ge.
A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma
[J]. Journal of International Oncology, 2024, 51(3): 151-156.
|
[4] |
Xie Shuping, Sun Yahong, Wang Chao.
Prediction of efficacy of early-stage tumor markers combined with NLR and PLR for immunotherapy in gastric cancer
[J]. Journal of International Oncology, 2024, 51(3): 157-165.
|
[5] |
He Jiahui, Hu Qinyong.
Comparative analysis of lung cancer incidence and mortality trends and risk factors in China and the United States based on GBD data
[J]. Journal of International Oncology, 2024, 51(1): 29-36.
|
[6] |
Chen Xinyi, Weng Yiming, Wei Jiayan, Wang Jinsong, Peng Min.
Advances in immune checkpoint inhibitors in the treatment of recurrent or metastatic head and neck squamous cell carcinoma
[J]. Journal of International Oncology, 2023, 50(9): 553-557.
|
[7] |
Deng Juanjun, Zhao Dayong, Li Miao.
Adverse reactions and risk factors of immune checkpoint inhibitors in the treatment of non-small cell lung cancer
[J]. Journal of International Oncology, 2023, 50(9): 564-568.
|
[8] |
Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying.
Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer
[J]. Journal of International Oncology, 2023, 50(8): 475-483.
|
[9] |
Guo Ciliang, Jiang Chunping, Wu Junhua.
Gut microbiome and tumor immunotherapy
[J]. Journal of International Oncology, 2023, 50(7): 432-436.
|
[10] |
Liu Li, Zhu Siqi, Sun Mengying, He Jingdong.
Progress of PARP inhibitors in targeted therapy of small cell lung cancer
[J]. Journal of International Oncology, 2023, 50(6): 368-372.
|
[11] |
Gu Anqin, Long Jinhua, Jin Feng.
Clinical research progress of immunotherapy for nasopharyngeal carcinoma
[J]. Journal of International Oncology, 2023, 50(5): 299-303.
|
[12] |
Wang Yaqian, Du Yiwei, Wang Xing, Jia Junmei.
Prognostic predictors of immunotherapy in patients with small cell lung cancer
[J]. Journal of International Oncology, 2023, 50(3): 179-182.
|
[13] |
Ji Wei, Guan Quanlin, Chen Yarui, Jiao Fuzhi, Luo Qianwen.
Correlation between blood lipid level and gastric cancer
[J]. Journal of International Oncology, 2023, 50(3): 183-185.
|
[14] |
Li Lixi, Zhang Di, Luo Yang, Ma Fei.
Clinical application of PARP inhibitors in breast cancer
[J]. Journal of International Oncology, 2023, 50(2): 91-96.
|
[15] |
Zhang Bixia, Ding Jianghua.
Immunotherapy for EGFR-mutant non-small cell lung cancer after EGFR-TKI acquired resistance
[J]. Journal of International Oncology, 2023, 50(2): 97-101.
|